世界の抗老化療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anti-Senescence Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3836
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、抗老化療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子治療、免疫療法、その他）、用途別市場規模（循環器疾患、神経変性疾患、眼科疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・抗老化療法の市場動向
・企業の競争状況、市場シェア
・抗老化療法の種類別市場規模と予測2016-2027（遺伝子治療、免疫療法、その他）
・抗老化療法の用途別市場規模と予測2016-2027（循環器疾患、神経変性疾患、眼科疾患、その他）
・抗老化療法の北米市場規模2016-2027（アメリカ、カナダ）
・抗老化療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・抗老化療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・抗老化療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・抗老化療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Unity Biotechnology、Siwa Therapeutics、Calico LLC、AgeX Therapeutics，Inc、Numeric Biotech、Human Longevity, Inc. (HLI)、Cleara Biotech、OisinBiotechnologies、Recursion Pharmaceuticals、Sierra Sciences、Proteostasis Therapeutics、Senolytic Therapeutics、Allergan）
・結論

Various biomolecules in the system have a large number of active groups, which must interact with each other to produce chemical reactions and slowly cross-link the biomolecules so as to stabilize the chemical activity.With the passage of time, the degree of crosslinking keeps increasing, the consumption of active groups of biological molecules keeps decreasing, and the original molecular structure gradually changes. The accumulation of these changes will gradually lead to the aging phenomenon of biological tissues.Anti-aging treatments include gene therapy, immunotherapy, attention to diseases of the elderly, and so on.

Market Analysis and Insights: Global Anti-Senescence Therapy Market
The global Anti-Senescence Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-Senescence Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-Senescence Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-Senescence Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-Senescence Therapy market.

Global Anti-Senescence Therapy Scope and Market Size
Anti-Senescence Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Senescence Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gene Therapy
Immunotherapy
Others

Segment by Application
Cardiovascular Diseases
Neural Degenerative Diseases
Ophthalmology Disorders
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Unity Biotechnology
Siwa Therapeutics
Calico LLC
AgeX Therapeutics，Inc
Numeric Biotech
Human Longevity, Inc. (HLI)
Cleara Biotech
OisinBiotechnologies
Recursion Pharmaceuticals
Sierra Sciences
Proteostasis Therapeutics
Senolytic Therapeutics
Allergan

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Senescence Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gene Therapy
1.2.3 Immunotherapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anti-Senescence Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular Diseases
1.3.3 Neural Degenerative Diseases
1.3.4 Ophthalmology Disorders
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti-Senescence Therapy Market Perspective (2016-2027)
2.2 Anti-Senescence Therapy Growth Trends by Regions
2.2.1 Anti-Senescence Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-Senescence Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Anti-Senescence Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Anti-Senescence Therapy Industry Dynamic
2.3.1 Anti-Senescence Therapy Market Trends
2.3.2 Anti-Senescence Therapy Market Drivers
2.3.3 Anti-Senescence Therapy Market Challenges
2.3.4 Anti-Senescence Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti-Senescence Therapy Players by Revenue
3.1.1 Global Top Anti-Senescence Therapy Players by Revenue (2016-2021)
3.1.2 Global Anti-Senescence Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Anti-Senescence Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Senescence Therapy Revenue
3.4 Global Anti-Senescence Therapy Market Concentration Ratio
3.4.1 Global Anti-Senescence Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Senescence Therapy Revenue in 2020
3.5 Anti-Senescence Therapy Key Players Head office and Area Served
3.6 Key Players Anti-Senescence Therapy Product Solution and Service
3.7 Date of Enter into Anti-Senescence Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Senescence Therapy Breakdown Data by Type
4.1 Global Anti-Senescence Therapy Historic Market Size by Type (2016-2021)
4.2 Global Anti-Senescence Therapy Forecasted Market Size by Type (2022-2027)

5 Anti-Senescence Therapy Breakdown Data by Application
5.1 Global Anti-Senescence Therapy Historic Market Size by Application (2016-2021)
5.2 Global Anti-Senescence Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti-Senescence Therapy Market Size (2016-2027)
6.2 North America Anti-Senescence Therapy Market Size by Type
6.2.1 North America Anti-Senescence Therapy Market Size by Type (2016-2021)
6.2.2 North America Anti-Senescence Therapy Market Size by Type (2022-2027)
6.2.3 North America Anti-Senescence Therapy Market Size by Type (2016-2027)
6.3 North America Anti-Senescence Therapy Market Size by Application
6.3.1 North America Anti-Senescence Therapy Market Size by Application (2016-2021)
6.3.2 North America Anti-Senescence Therapy Market Size by Application (2022-2027)
6.3.3 North America Anti-Senescence Therapy Market Size by Application (2016-2027)
6.4 North America Anti-Senescence Therapy Market Size by Country
6.4.1 North America Anti-Senescence Therapy Market Size by Country (2016-2021)
6.4.2 North America Anti-Senescence Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anti-Senescence Therapy Market Size (2016-2027)
7.2 Europe Anti-Senescence Therapy Market Size by Type
7.2.1 Europe Anti-Senescence Therapy Market Size by Type (2016-2021)
7.2.2 Europe Anti-Senescence Therapy Market Size by Type (2022-2027)
7.2.3 Europe Anti-Senescence Therapy Market Size by Type (2016-2027)
7.3 Europe Anti-Senescence Therapy Market Size by Application
7.3.1 Europe Anti-Senescence Therapy Market Size by Application (2016-2021)
7.3.2 Europe Anti-Senescence Therapy Market Size by Application (2022-2027)
7.3.3 Europe Anti-Senescence Therapy Market Size by Application (2016-2027)
7.4 Europe Anti-Senescence Therapy Market Size by Country
7.4.1 Europe Anti-Senescence Therapy Market Size by Country (2016-2021)
7.4.2 Europe Anti-Senescence Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti-Senescence Therapy Market Size (2016-2027)
8.2 Asia-Pacific Anti-Senescence Therapy Market Size by Type
8.2.1 Asia-Pacific Anti-Senescence Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-Senescence Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-Senescence Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-Senescence Therapy Market Size by Application
8.3.1 Asia-Pacific Anti-Senescence Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-Senescence Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-Senescence Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-Senescence Therapy Market Size by Region
8.4.1 Asia-Pacific Anti-Senescence Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-Senescence Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti-Senescence Therapy Market Size (2016-2027)
9.2 Latin America Anti-Senescence Therapy Market Size by Type
9.2.1 Latin America Anti-Senescence Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Anti-Senescence Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Anti-Senescence Therapy Market Size by Type (2016-2027)
9.3 Latin America Anti-Senescence Therapy Market Size by Application
9.3.1 Latin America Anti-Senescence Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Anti-Senescence Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Anti-Senescence Therapy Market Size by Application (2016-2027)
9.4 Latin America Anti-Senescence Therapy Market Size by Country
9.4.1 Latin America Anti-Senescence Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Anti-Senescence Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti-Senescence Therapy Market Size (2016-2027)
10.2 Middle East & Africa Anti-Senescence Therapy Market Size by Type
10.2.1 Middle East & Africa Anti-Senescence Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-Senescence Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-Senescence Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-Senescence Therapy Market Size by Application
10.3.1 Middle East & Africa Anti-Senescence Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-Senescence Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-Senescence Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-Senescence Therapy Market Size by Country
10.4.1 Middle East & Africa Anti-Senescence Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-Senescence Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Unity Biotechnology
11.1.1 Unity Biotechnology Company Details
11.1.2 Unity Biotechnology Business Overview
11.1.3 Unity Biotechnology Anti-Senescence Therapy Introduction
11.1.4 Unity Biotechnology Revenue in Anti-Senescence Therapy Business (2016-2021)
11.1.5 Unity Biotechnology Recent Development
11.2 Siwa Therapeutics
11.2.1 Siwa Therapeutics Company Details
11.2.2 Siwa Therapeutics Business Overview
11.2.3 Siwa Therapeutics Anti-Senescence Therapy Introduction
11.2.4 Siwa Therapeutics Revenue in Anti-Senescence Therapy Business (2016-2021)
11.2.5 Siwa Therapeutics Recent Development
11.3 Calico LLC
11.3.1 Calico LLC Company Details
11.3.2 Calico LLC Business Overview
11.3.3 Calico LLC Anti-Senescence Therapy Introduction
11.3.4 Calico LLC Revenue in Anti-Senescence Therapy Business (2016-2021)
11.3.5 Calico LLC Recent Development
11.4 AgeX Therapeutics，Inc
11.4.1 AgeX Therapeutics，Inc Company Details
11.4.2 AgeX Therapeutics，Inc Business Overview
11.4.3 AgeX Therapeutics，Inc Anti-Senescence Therapy Introduction
11.4.4 AgeX Therapeutics，Inc Revenue in Anti-Senescence Therapy Business (2016-2021)
11.4.5 AgeX Therapeutics，Inc Recent Development
11.5 Numeric Biotech
11.5.1 Numeric Biotech Company Details
11.5.2 Numeric Biotech Business Overview
11.5.3 Numeric Biotech Anti-Senescence Therapy Introduction
11.5.4 Numeric Biotech Revenue in Anti-Senescence Therapy Business (2016-2021)
11.5.5 Numeric Biotech Recent Development
11.6 Human Longevity, Inc. (HLI)
11.6.1 Human Longevity, Inc. (HLI) Company Details
11.6.2 Human Longevity, Inc. (HLI) Business Overview
11.6.3 Human Longevity, Inc. (HLI) Anti-Senescence Therapy Introduction
11.6.4 Human Longevity, Inc. (HLI) Revenue in Anti-Senescence Therapy Business (2016-2021)
11.6.5 Human Longevity, Inc. (HLI) Recent Development
11.7 Cleara Biotech
11.7.1 Cleara Biotech Company Details
11.7.2 Cleara Biotech Business Overview
11.7.3 Cleara Biotech Anti-Senescence Therapy Introduction
11.7.4 Cleara Biotech Revenue in Anti-Senescence Therapy Business (2016-2021)
11.7.5 Cleara Biotech Recent Development
11.8 OisinBiotechnologies
11.8.1 OisinBiotechnologies Company Details
11.8.2 OisinBiotechnologies Business Overview
11.8.3 OisinBiotechnologies Anti-Senescence Therapy Introduction
11.8.4 OisinBiotechnologies Revenue in Anti-Senescence Therapy Business (2016-2021)
11.8.5 OisinBiotechnologies Recent Development
11.9 Recursion Pharmaceuticals
11.9.1 Recursion Pharmaceuticals Company Details
11.9.2 Recursion Pharmaceuticals Business Overview
11.9.3 Recursion Pharmaceuticals Anti-Senescence Therapy Introduction
11.9.4 Recursion Pharmaceuticals Revenue in Anti-Senescence Therapy Business (2016-2021)
11.9.5 Recursion Pharmaceuticals Recent Development
11.10 Sierra Sciences
11.10.1 Sierra Sciences Company Details
11.10.2 Sierra Sciences Business Overview
11.10.3 Sierra Sciences Anti-Senescence Therapy Introduction
11.10.4 Sierra Sciences Revenue in Anti-Senescence Therapy Business (2016-2021)
11.10.5 Sierra Sciences Recent Development
11.11 Proteostasis Therapeutics
11.11.1 Proteostasis Therapeutics Company Details
11.11.2 Proteostasis Therapeutics Business Overview
11.11.3 Proteostasis Therapeutics Anti-Senescence Therapy Introduction
11.11.4 Proteostasis Therapeutics Revenue in Anti-Senescence Therapy Business (2016-2021)
11.11.5 Proteostasis Therapeutics Recent Development
11.12 Senolytic Therapeutics
11.12.1 Senolytic Therapeutics Company Details
11.12.2 Senolytic Therapeutics Business Overview
11.12.3 Senolytic Therapeutics Anti-Senescence Therapy Introduction
11.12.4 Senolytic Therapeutics Revenue in Anti-Senescence Therapy Business (2016-2021)
11.12.5 Senolytic Therapeutics Recent Development
11.13 Allergan
11.13.1 Allergan Company Details
11.13.2 Allergan Business Overview
11.13.3 Allergan Anti-Senescence Therapy Introduction
11.13.4 Allergan Revenue in Anti-Senescence Therapy Business (2016-2021)
11.13.5 Allergan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anti-Senescence Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gene Therapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Others
Table 5. Global Anti-Senescence Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-Senescence Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti-Senescence Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Anti-Senescence Therapy Market Share by Regions (2016-2021)
Table 9. Global Anti-Senescence Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Anti-Senescence Therapy Market Share by Regions (2022-2027)
Table 11. Anti-Senescence Therapy Market Trends
Table 12. Anti-Senescence Therapy Market Drivers
Table 13. Anti-Senescence Therapy Market Challenges
Table 14. Anti-Senescence Therapy Market Restraints
Table 15. Global Anti-Senescence Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Anti-Senescence Therapy Market Share by Players (2016-2021)
Table 17. Global Top Anti-Senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Senescence Therapy as of 2020)
Table 18. Ranking of Global Top Anti-Senescence Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Anti-Senescence Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti-Senescence Therapy Product Solution and Service
Table 22. Date of Enter into Anti-Senescence Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-Senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Anti-Senescence Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Anti-Senescence Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Anti-Senescence Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Anti-Senescence Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Anti-Senescence Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Anti-Senescence Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Anti-Senescence Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Anti-Senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Anti-Senescence Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Anti-Senescence Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Anti-Senescence Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Anti-Senescence Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Anti-Senescence Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Anti-Senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Anti-Senescence Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Anti-Senescence Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Anti-Senescence Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Anti-Senescence Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Anti-Senescence Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Anti-Senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Anti-Senescence Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anti-Senescence Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anti-Senescence Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-Senescence Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Anti-Senescence Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Anti-Senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Anti-Senescence Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Anti-Senescence Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Anti-Senescence Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Anti-Senescence Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Anti-Senescence Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Anti-Senescence Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Anti-Senescence Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anti-Senescence Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anti-Senescence Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-Senescence Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Anti-Senescence Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Unity Biotechnology Company Details
Table 63. Unity Biotechnology Business Overview
Table 64. Unity Biotechnology Anti-Senescence Therapy Product
Table 65. Unity Biotechnology Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 66. Unity Biotechnology Recent Development
Table 67. Siwa Therapeutics Company Details
Table 68. Siwa Therapeutics Business Overview
Table 69. Siwa Therapeutics Anti-Senescence Therapy Product
Table 70. Siwa Therapeutics Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 71. Siwa Therapeutics Recent Development
Table 72. Calico LLC Company Details
Table 73. Calico LLC Business Overview
Table 74. Calico LLC Anti-Senescence Therapy Product
Table 75. Calico LLC Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 76. Calico LLC Recent Development
Table 77. AgeX Therapeutics，Inc Company Details
Table 78. AgeX Therapeutics，Inc Business Overview
Table 79. AgeX Therapeutics，Inc Anti-Senescence Therapy Product
Table 80. AgeX Therapeutics，Inc Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 81. AgeX Therapeutics，Inc Recent Development
Table 82. Numeric Biotech Company Details
Table 83. Numeric Biotech Business Overview
Table 84. Numeric Biotech Anti-Senescence Therapy Product
Table 85. Numeric Biotech Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 86. Numeric Biotech Recent Development
Table 87. Human Longevity, Inc. (HLI) Company Details
Table 88. Human Longevity, Inc. (HLI) Business Overview
Table 89. Human Longevity, Inc. (HLI) Anti-Senescence Therapy Product
Table 90. Human Longevity, Inc. (HLI) Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 91. Human Longevity, Inc. (HLI) Recent Development
Table 92. Cleara Biotech Company Details
Table 93. Cleara Biotech Business Overview
Table 94. Cleara Biotech Anti-Senescence Therapy Product
Table 95. Cleara Biotech Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 96. Cleara Biotech Recent Development
Table 97. OisinBiotechnologies Company Details
Table 98. OisinBiotechnologies Business Overview
Table 99. OisinBiotechnologies Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 100. OisinBiotechnologies Recent Development
Table 101. Recursion Pharmaceuticals Company Details
Table 102. Recursion Pharmaceuticals Business Overview
Table 103. Recursion Pharmaceuticals Anti-Senescence Therapy Product
Table 104. Recursion Pharmaceuticals Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 105. Recursion Pharmaceuticals Recent Development
Table 106. Sierra Sciences Company Details
Table 107. Sierra Sciences Business Overview
Table 108. Sierra Sciences Anti-Senescence Therapy Product
Table 109. Sierra Sciences Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 110. Sierra Sciences Recent Development
Table 111. Proteostasis Therapeutics Company Details
Table 112. Proteostasis Therapeutics Business Overview
Table 113. Proteostasis Therapeutics Anti-Senescence Therapy Product
Table 114. Proteostasis Therapeutics Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 115. Proteostasis Therapeutics Recent Development
Table 116. Senolytic Therapeutics Company Details
Table 117. Senolytic Therapeutics Business Overview
Table 118. Senolytic Therapeutics Anti-Senescence Therapy Product
Table 119. Senolytic Therapeutics Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 120. Senolytic Therapeutics Recent Development
Table 121. Allergan Company Details
Table 122. Allergan Business Overview
Table 123. Allergan Anti-Senescence Therapy Product
Table 124. Allergan Revenue in Anti-Senescence Therapy Business (2016-2021) & (US$ Million)
Table 125. Allergan Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Senescence Therapy Market Share by Type: 2020 VS 2027
Figure 2. Gene Therapy Features
Figure 3. Immunotherapy Features
Figure 4. Others Features
Figure 5. Global Anti-Senescence Therapy Market Share by Application: 2020 VS 2027
Figure 6. Cardiovascular Diseases Case Studies
Figure 7. Neural Degenerative Diseases Case Studies
Figure 8. Ophthalmology Disorders Case Studies
Figure 9. Others Case Studies
Figure 10. Anti-Senescence Therapy Report Years Considered
Figure 11. Global Anti-Senescence Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Anti-Senescence Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anti-Senescence Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Anti-Senescence Therapy Market Share by Regions (2022-2027)
Figure 15. Global Anti-Senescence Therapy Market Share by Players in 2020
Figure 16. Global Top Anti-Senescence Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Senescence Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Anti-Senescence Therapy Revenue in 2020
Figure 18. Global Anti-Senescence Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Anti-Senescence Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Anti-Senescence Therapy Market Share by Type (2016-2027)
Figure 22. North America Anti-Senescence Therapy Market Share by Application (2016-2027)
Figure 23. North America Anti-Senescence Therapy Market Share by Country (2016-2027)
Figure 24. United States Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anti-Senescence Therapy Market Share by Type (2016-2027)
Figure 28. Europe Anti-Senescence Therapy Market Share by Application (2016-2027)
Figure 29. Europe Anti-Senescence Therapy Market Share by Country (2016-2027)
Figure 30. Germany Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anti-Senescence Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Anti-Senescence Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Anti-Senescence Therapy Market Share by Region (2016-2027)
Figure 40. China Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anti-Senescence Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Anti-Senescence Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Anti-Senescence Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anti-Senescence Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Anti-Senescence Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Anti-Senescence Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Anti-Senescence Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Unity Biotechnology Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 60. Siwa Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 61. Calico LLC Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 62. AgeX Therapeutics，Inc Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 63. Numeric Biotech Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 64. Human Longevity, Inc. (HLI) Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 65. Cleara Biotech Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 66. OisinBiotechnologies Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 67. Recursion Pharmaceuticals Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 68. Sierra Sciences Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 69. Proteostasis Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 70. Senolytic Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 71. Allergan Revenue Growth Rate in Anti-Senescence Therapy Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の長寿＆老化防止治療市場規模・現状・予測（2021年-2027年）

Global Longevity and Anti-senescence Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4440 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、長寿＆老化防止治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（溶血性薬物療法、遺伝子治療、免疫療法、その他幹細胞治療）、用途別市場規模（病院、医療機関、医薬品・機器販売）、主要地域別市場規模（北米...

世界の抗腫瘍療法市場規模・現状・予測（2021年-2027年）

Global Anti-Neoplastic Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3831 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、抗腫瘍療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法剤、免疫療法剤、個別化医療）、用途別市場規模（病院、診療所、がんリハビリセンター、外来手術センター）、主要地域別市場規模（北米、アメリ...

世界のT細胞療法市場規模・現状・予測（2021年-2027年）

Global T-Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4937 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、T細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CAR T細胞療法、TCR療法、TIL療法）、用途別市場規模（病院、診療所・外来センター、がん研究所、その他）、主要地域別市場規模（北米、アメ...

世界の自己細胞療法市場規模・現状・予測（2021年-2027年）

Global Autologous Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3873 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、自己細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（骨髄、表皮）、用途別市場規模（神経内科、整形外科、がん、創傷治癒、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の遺伝子治療医学市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Medicine Market Size, Status and Forecast 2021-2027
QFJ1-5751 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、遺伝子治療医学の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のTCR療法市場規模・現状・予測（2021年-2027年）

Global TCR Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4939 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、TCR療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（キメラ抗原受容体シグナル伝達、TCRα/βヘテロダイマーシグナル伝達）、用途別市場規模（病院、診療所・外来センター、がん研究所、その他）、主要...

世界の抗感染症療法市場規模・現状・予測（2021年-2027年）

Global Anti-Infective Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5585 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、抗感染症療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペニシリン、スルホンアミド、アミノグリコシド、フルオロキノロン、抗真菌剤、抗原虫剤、その他）、用途別市場規模（家庭用、病院/診療所、外来手術...

世界の遺伝子治療医薬品（GTMP）市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Medicinal Products (GTMP) Market Size, Status and Forecast 2021-2027
QFJ1-5750 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、遺伝子治療医薬品（GTMP）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5749 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、遺伝子治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（神経筋疾患、遺伝病、その他）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の多血小板血漿療法市場規模・現状・予測（2021年-2027年）

Global Platelet-rich Plasma Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5954 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、多血小板血漿療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（純PRP、白血球豊富型PRP、白血球豊富型フィブリン（L-PRF））、用途別市場規模（整形外科、皮膚科、心筋損傷、歯科、神経損傷、その他...

世界の長寿＆老化防止治療市場規模・現状・予測（2021年-2027年） Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…
老化防止療法のグローバル市場：規模・現状・予測2019-2025 Various biomolecules in the system have a large number of active groups, which must interact with each other to produce chemical reactions and slowly cross-link the biomolecules so as to stabilize the chemical activity.With the passage of time, the degree of crosslinking keeps increasing, the consum…
老化防止療法のグローバル市場：規模・現状・予測2019-2025 Various biomolecules in the system have a large number of active groups, which must interact with each other to produce chemical reactions and slowly cross-link the biomolecules so as to stabilize the chemical activity.With the passage of time, the degree of crosslinking keeps increasing, the consum…
長寿及び抗老化療法のグローバル市場：規模・現状・予測2019-2025 Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…
長寿及び抗老化療法のグローバル市場：規模・現状・予測2019-2025 Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…